The Neurofibromatosis Therapeutic Acceleration Program (NTAP) is now accepting applications for the Francis S. Collins Scholars Program in Neurofibromatosis Clinical and Translational Research. The Collins Scholars program brings together a community of exceptionally well-trained clinician scientists who will be leaders in the field of NF1 research.
Explicitly designed to attract talent of the highest order to the field of NF1 research and to foster life-long commitment to this syndrome, the program invests in its scholars by providing formal training in the discipline of clinical translational science, the time to develop the skills appropriate for their research, exposure to translational research programs in government, academic, and industry environments and training in the care of patients with NF1.
The program is designed to attract the most talented and promising clinician scientists to conduct patient focused research in NF1. Candidates must be in their last stages of post-doctoral training or in the first seven years on faculty, have a commitment to patient-focused research, have demonstrated research experience, have an interest in NF1 and have appropriate mentorship. NTAP is hopeful to receive applications from candidates around the world across all disciplines of medicine with an interest in NF1.
The Scholars Program is named in honor of Dr. Francis S. Collins, who as an exemplary physician scientist led the team that discovered the NF1 gene in 1990. This discovery has informed virtually all subsequent clinical-translational NF1 research.
The deadline for grant submission is December 21, 2020. For more information about NTAP please visit www.n-tap.org.
Click to download an application to the Francis S. Collins Scholars Program in Neurofibromatosis Clinical and Translational Research.
